GLP-1 Drugs May Lower Cancer Risk | Health and Fitness News

Health News Today | 2 Min News | The Daily News Now! · Jun 30, 2026 · 2m

New research reveals GLP-1 drugs—popular for weight loss and diabetes—might slash cancer risk, especially for breast, colorectal, and liver cancers, by tackling metabolic drivers like insulin spikes and inflammation. While not yet approved for cancer prevention, early studies show promising trends, including reduced breast cancer cases in women. Scientists are exploring whether these meds can even halt tumor growth or trigger cell death, but more trials are needed. Experts caution they’re not a substitute for healthy habits or screenings, but could become a powerful tool for high-risk…